Roots Announces Results of Voting at Fiscal 2024 Annual and Special Meeting of Shareholders and Changes to Board of Directors ...

DevvStream Corp. (Nasdaq: DEVS) ("DevvStream" or the "Company"), a leading carbon management firm specializing in the development, investment, and sale of environmental assets, today announced the ...

DREAM INDUSTRIAL REIT (TSX: DIR.UN) (the "Trust") announced today its July 2025 monthly distribution in the amount of 5.833 cents per Unit (70 cents annualized). The July distribution will be payable ...

Soluna Closes $20M Funding from Spring Lane Capital to Begin Construction on Project Kati 1 With these funds, Soluna will commence Project Kati 1 construction in Q3 2025, with the goal of achieving ...

Acquisition brings proprietary media planning and analytics tools into Real Chemistry's platform – enhancing strategy, performance and measurable impact for pharma and biotech clients.

AECOM awarded three U.S. Army Corps of Engineers contracts to support critical infrastructure modernization across the Pacific Region ...

The comedy Menteuse is likely to be the big draw at cinemas, but there’s also plenty of live music, at Soulfest, Nuits ...

Zoho Corporation, a global technology company, today announced additional investments and offerings in AI, including Zia LLM, a proprietary large language model; Zia Agents, with 25+ ready-to-deploy ...

American satirist supreme Roy Wood Jr. will have plenty of political fodder for his Just for Laughs gala and solo show.

Treasure Data's AI Agent Foundry Is Now Available in the New AWS Marketplace AI Agents and Tools Category . Press contact Staley White [email protected] . Treasure Data, the ...

But things have changed. Today, 45 percent of EV owners report facing no challenges at all while road-tripping1. One factor behind this shift is the arrival of reliable, long-range electric vehicles ...

First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synov ...